[Subcutaneous continuous apomorphine infusion: treatment initiation and follow up]

Rev Neurol. 2012:55 Suppl 1:S21-4.
[Article in Spanish]

Abstract

Continuous apomorphine infusion has been an established treatment for advanced Parkinson's disease for over two decades. This article reviews the different methods for starting treatment and propose a consensus methodology for it, as well as for the modification of prior treatment, in order to standardize and reduce the variability of clinical practice.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Aftercare
  • Ambulatory Care
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / therapeutic use*
  • Apomorphine / administration & dosage
  • Apomorphine / adverse effects
  • Apomorphine / therapeutic use*
  • Benserazide / therapeutic use
  • Carbidopa / therapeutic use
  • Caregivers
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Humans
  • Infusions, Subcutaneous / standards
  • Levodopa / therapeutic use
  • Parkinson Disease / drug therapy*
  • Patient Education as Topic
  • Patient Selection
  • Retrospective Studies

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Levodopa
  • Benserazide
  • Carbidopa
  • Apomorphine